This inventor holds 6 USPTO granted patents and 6 published patent applications. Top assignee: Intervet Inc.. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Mark A Mogler: Innovator in Veterinary Vaccines
Introduction
Mark A Mogler is a prominent inventor based in Ames, Iowa, known for his contributions to veterinary medicine. He holds a total of 6 patents that focus on innovative vaccine technologies aimed at combating animal diseases. His work has significantly advanced the field of veterinary immunology.
Latest Patents
Among his latest patents is a vaccine for the Swine Influenza A virus. This invention provides vectors and/or nucleic acid constructs that encode one or more influenza A virus neuraminidase (NA) antigens. The vaccine comprises these vectors and/or constructs, along with methods for making and using the vaccines, either alone or in combination with other protective agents. Another notable patent involves vaccination against animal pathogens using alphavirus-replicon RNA particles and oil adjuvants. This invention includes a vaccine and a kit comprising the replicon particles and the oil adjuvant, along with methods for their use.
Career Highlights
Mark A Mogler is associated with Intervet Inc., a company dedicated to developing innovative solutions for animal health. His work at Intervet has allowed him to focus on creating effective vaccines that address critical health issues in livestock.
Collaborations
Throughout his career, Mogler has collaborated with notable colleagues, including Erin Linn Strait and Ruud Philip Antoon Maria Segers. These collaborations have contributed to the success of his research and the development of his patents.
Conclusion
Mark A Mogler's innovative work in veterinary vaccines has made a significant impact on animal health. His patents reflect a commitment to advancing veterinary medicine through scientific research and collaboration.